Jasper Therapeutics Inc (JSPR)
22.98
+0.14
(+0.59%)
USD |
NASDAQ |
May 17, 16:00
22.98
0.00 (0.00%)
After-Hours: 20:00
Jasper Therapeutics Shareholders Equity (Quarterly): 113.23M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 113.23M |
December 31, 2023 | 78.44M |
September 30, 2023 | 94.13M |
June 30, 2023 | 110.20M |
March 31, 2023 | 125.20M |
December 31, 2022 | 35.99M |
Date | Value |
---|---|
September 30, 2022 | 47.56M |
June 30, 2022 | 58.78M |
March 31, 2022 | 68.10M |
December 31, 2021 | 69.52M |
September 30, 2021 | 78.60M |
December 31, 2020 | -35.13M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-35.13M
Minimum
Dec 2020
125.20M
Maximum
Mar 2023
70.39M
Average
73.98M
Median
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 0.16M |
Palatin Technologies Inc | 1.579M |
iBio Inc | 9.197M |
Theriva Biologics Inc | 34.12M |
Oragenics Inc | 3.168M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 125.96M |
Total Liabilities (Quarterly) | 12.73M |